Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 09, 2018
CrownSyn is now available as an add-on feature to all two-drug combinatorial studies conducted by Crown Bioscience.
read more
Tjoapack and Veratrak, have launched the European Platform on Changing Healthcare (EPOCH) as part of their ongoing partnership dedicated to improving pharmaceutical supply chain operations.
read more
Thursday, January 10, 2019
MellingMedical announced a vital distribution relationship with Katena Products.
read more
Medidata announced that BeiGene will expand its use of the Medidata Clinical Cloud to further digitize patient reporting for its oncology research studies.
read more
Bicycle Therapeutics announced it is expanding its collaboration with AstraZeneca to include additional targets in respiratory and cardio-metabolic diseases.
read more
Wednesday, March 04, 2020
Samsung Biologics and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate.
read more
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
read more
Mayne Pharma has entered into a long-term exclusive license and supply agreement with Mithra Pharmaceuticals SA (Mithra) for Myring®, an intravaginal hormonal contraceptive delivery device.
read more
Neovii and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon, in China and Japan.
read more
Exyte and Univercells Technologies are announcing a global partnership for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.
read more
Friday, November 06, 2020
Lonza inaugurated the first of two manufacturing suites for ADC drug-linker manufacturing at the Visp (CH) site.
read more
I Peace, Inc. announced that the company has tripled its capacity to manufacture GMP grade iPS cells and iPSC-derived differentiated cells by expanding its facility. The facility's expansion, designed to conform to GMP standard, is now almost ...
read more
Radiant Clinical Research is expanding the scope of its Central Nervous System (CNS) studies. This expansion is in response to a growing need for qualified sites that have the expertise to conduct pharmaceutical trials for the treatment of ...
read more
Meissa Vaccines announced it has been awarded a Phase 1 SBIR grant by the National Institutes of Health entitled "Development of polyvalent inactivated rhinovirus vaccine."
read more
Monday, September 16, 2019
LabCorp® announced its Covance Drug Development business announces the opening of its new R&D Center in Shanghai, China.
read more